Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on Tuesday, February 6, 2024
23 Janeiro 2024 - 6:05PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its
fourth quarter and full year 2023 financial results and guidance
will be released on Tuesday, February 6, 2024 after the market
closes. At 5:00 p.m. Eastern Time that day, Gilead’s management
will host a webcast to discuss the company’s fourth quarter and
full year 2023 financial results and provide a business update.
A live webcast will be available on the Investor Relations
section of www.gilead.com and will be archived there for one
year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis, COVID-19, and cancer. Gilead operates in more than
35 countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240123115550/en/
Jacquie Ross, CFA – Investors investor_relations@gilead.com
Gilead Sciences (NASDAQ:GILD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Gilead Sciences (NASDAQ:GILD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024